Phase 4 Pneumococcal disease Clinical Trials

4 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–4 of 4 trials

Recruiting

Phase 4

Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

VaccinePneumococcal disease

University of Alabama at Birmingham70 enrolled1 locationNCT07135453

Recruiting

Phase 4

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

Pneumococcal CarriagePneumococcal disease

University of Oxford106 enrolled2 locationsNCT06731374

Recruiting

Phase 3Phase 4

A randomised controlled trial of pneumococcal conjugate vaccines Synflorix and Prevenar13 in sequence or alone in high-risk Indigenous infants (PREV-IX): immunogenicity, carriage and otitis media outcomes

Non-typeable Haemophilus influenzae diseaseOtitis media in Indigenous infantsPneumococcal disease

Menzies School of Health Research425 enrolled1 locationACTRN12610000544077

Completed

Phase 3Phase 4

The immunogenicity of the new pneumococcal conjugate vaccine in the elderly

Pneumococcal disease

Professor C Raina MacIntyre315 enrolled1 locationACTRN12607000387426